229 related articles for article (PubMed ID: 16300956)
1. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
[TBL] [Abstract][Full Text] [Related]
3. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.
Grandoso L; Ponce S; Manuel I; Arrúe A; Ruiz-Ortega JA; Ulibarri I; Orive G; Hernández RM; Rodríguez A; Rodríguez-Puertas R; Zumárraga M; Linazasoro G; Pedraz JL; Ugedo L
Int J Pharm; 2007 Oct; 343(1-2):69-78. PubMed ID: 17583454
[TBL] [Abstract][Full Text] [Related]
5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
Shingo T; Date I; Yoshida H; Ohmoto T
J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
[TBL] [Abstract][Full Text] [Related]
7. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
Brizard M; Carcenac C; Bemelmans AP; Feuerstein C; Mallet J; Savasta M
Neurobiol Dis; 2006 Jan; 21(1):90-101. PubMed ID: 16084732
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
9. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
10. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.
Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Takeuchi A; Ohmoto T
Cell Transplant; 2001; 10(4-5):397-401. PubMed ID: 11549061
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor.
Jingzhong Z; Hui Y; Deyi D; Chunli D; Chunli Z; Xiaohong S; Jinlu Z; Qunyuan X
Int J Neurosci; 2005 Jun; 115(6):769-79. PubMed ID: 16019573
[TBL] [Abstract][Full Text] [Related]
12. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
13. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
14. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease.
Duan D; Yang H; Zhang J; Zhang J; Xu Q
Exp Brain Res; 2005 Mar; 161(3):316-24. PubMed ID: 15480595
[TBL] [Abstract][Full Text] [Related]
15. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
Ahn YH; Bensadoun JC; Aebischer P; Zurn AD; Seiger A; Björklund A; Lindvall O; Wahlberg L; Brundin P; Kaminski Schierle GS
Brain Res Bull; 2005 Jul; 66(2):135-42. PubMed ID: 15982530
[TBL] [Abstract][Full Text] [Related]
16. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
[TBL] [Abstract][Full Text] [Related]
17. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
19. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
[TBL] [Abstract][Full Text] [Related]
20. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.
Shyu WC; Li KW; Peng HF; Lin SZ; Liu RS; Wang HJ; Su CY; Lee YJ; Li H
J Neurosci Res; 2009 Jul; 87(9):2020-33. PubMed ID: 19235891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
